Literature DB >> 7240971

Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol.

M O Reynier, J C Montet, A Gerolami, C Marteau, C Crotte, A M Montet, S Mathieu.   

Abstract

Cholesterol absorption was studied in mice receiving cholic, chenodeoxycholic, or ursodeoxycholic acids (0.2% of the diet) for 2 months. Cholesterol absorption was greater with cholic acid (79%) than with chenodeoxycholic acid feeding (60%) and the lowest levels were observed during ursodeoxycholic acid feeding (37%). Under the three diets, bile acid pool and bile acid secretion were not different. Biliary cholesterol secretion was increased by cholic acid. The bile acid fed represents at least 80% of total bile acids. Micellar solubilization of oleic acid and cholesterol in the presence of each tauro-conjugated bile salt (10 mM) was determined in vitro by the coprecipitation method. Whatever the pH conditions, taurochenodeoxycholate solubilized significantly more cholesterol and more oleic acid than taurocholate. Tauroursodeoxycholate had the poorest detergent properties for both lipids. The differences between the three bile salts for cholesterol solubilization were enlarged by lowering pH and by high oleic acid concentration. Therefore the decrease in cholesterol absorption observed during ursodeoxycholic acid feeding could be explained by the poor detergent properties of this bile salt species. On the other hand, there is no relationship between the detergent properties of taurochenodeoxycholate and taurocholate and their effects on cholesterol absorption in mice. These results suggest that, in this particular case, micellar solubilization is not the rate limiting step in cholesterol absorption.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240971

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  23 in total

1.  Pancreatic lipase/colipase-mediated triacylglycerol hydrolysis is required for cholesterol transport from lipid emulsions to intestinal cells.

Authors:  S C Young; D Y Hui
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

Review 2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

Review 3.  Therapeutic uses of animal biles in traditional Chinese medicine: an ethnopharmacological, biophysical chemical and medicinal review.

Authors:  David Q-H Wang; Martin C Carey
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity.

Authors:  F A Klaver; R van der Meer
Journal:  Appl Environ Microbiol       Date:  1993-04       Impact factor: 4.792

5.  All-trans retinoic acid regulates hepatic bile acid homeostasis.

Authors:  Fan Yang; Yuqi He; Hui-Xin Liu; Jessica Tsuei; Xiaoyue Jiang; Li Yang; Zheng-Tao Wang; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2014-08-28       Impact factor: 5.858

6.  Effect of 7-methylated bile acids and bile alcohols on cholesterol metabolism in hamsters.

Authors:  N Matoba; S Kuroki; B I Cohen; E H Mosbach; C K McSherry
Journal:  Lipids       Date:  1988-05       Impact factor: 1.880

7.  An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties.

Authors:  Dora I A Pereira; Anne L McCartney; Glenn R Gibson
Journal:  Appl Environ Microbiol       Date:  2003-08       Impact factor: 4.792

Review 8.  Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.

Authors:  Manoj Kumar; Ravinder Nagpal; Rajesh Kumar; R Hemalatha; Vinod Verma; Ashok Kumar; Chaitali Chakraborty; Birbal Singh; Francesco Marotta; Shalini Jain; Hariom Yadav
Journal:  Exp Diabetes Res       Date:  2012-05-03

9.  Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice.

Authors:  Dany Gaillard; David Masson; Erwan Garo; Maamar Souidi; Jean-Paul Pais de Barros; Kristina Schoonjans; Jacques Grober; Philippe Besnard; Charles Thomas
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

10.  Investigation of microencapsulated BSH active lactobacillus in the simulated human GI tract.

Authors:  Christopher Martoni; Jasmine Bhathena; Mitchell Lawrence Jones; Aleksandra Malgorzata Urbanska; Hongmei Chen; Satya Prakash
Journal:  J Biomed Biotechnol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.